Deflazacort is used for: Allergic and inflammatory disorders.
Recorded in the NepalDoc medicine catalog for Deflazacort.
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) tablets.
From the U.S. FDA-approved label for Deflazacort. Full label: DailyMed.
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) tablets. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information.
From the U.S. FDA-approved label for Deflazacort. Full label: DailyMed.
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few days. 2.1 Assessments Prior to First Dose of Deflazacort Tablets Administer all immunizations according to immunization guidelines prior to starting deflazacort tablets.
Directions from the U.S. FDA-approved label for Deflazacort — your doctor or pharmacist may advise differently.
Deflazacort tablet is contraindicated in patients with known hypersensitivity to deflazacort or to any of the inactive ingredients. Instances of hypersensitivity, including anaphylaxis, have occurred in patients receiving corticosteroid therapy. Hypersensitivity to deflazacort or any of the inactive ingredients in deflazacort tablets.
Excerpt from the U.S. FDA-approved label for Deflazacort. Talk to a pharmacist or doctor before use.
Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome and hyperglycemia can occur; Monitor patients for these conditions with chronic use of deflazacort. Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal; Signs and symptoms of infection may be masked. Alterations in Cardiovascular/Renal Function: Monitor for elevated blood pressure and sodium and for decreased potassium levels.
Warnings and precautions excerpt from the U.S. FDA-approved label for Deflazacort — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are discussed in more detail in other sections: Alterations in Endocrine Function Immunosuppression and Increased Risk of Infection Alterations in Cardiovascular/Renal Function Gastrointestinal Perforation Behavioral and Mood Disturbances Effects on Bones Ophthalmic Effects Immunizations Serious Skin Rashes Effects on Growth and Development Myopathy Kaposi’s Sarcoma Thromboembolic…
Excerpt from the U.S. FDA-approved label for Deflazacort — not a complete list. Talk to a pharmacist or doctor about side effects.
4 brands · 1 maker in the NepalDoc catalog — see the full Deflazacort guide →
Store at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label for Deflazacort.
What is Dezacor?
Dezacor 30ML Syrup is a Deflazacort medicine made by Aristo Pharmaceuticals Ltd. It comes as 30ML Syrup.
What is Dezacor used for?
Deflazacort is used for Allergic and inflammatory disorders.
What is the generic name of Dezacor?
The generic name of Dezacor is Deflazacort.
Which brands of Deflazacort are available in Nepal?
4 brands of Deflazacort are listed in the NepalDoc catalog, from 1 makers — including Dezacor 1mg Tablet, Dezacor 6mg Tablet, Dezacor 30mg Tablet.
What are the side effects of Deflazacort?
The following serious adverse reactions are discussed in more detail in other sections: Alterations in Endocrine Function Immunosuppression and Increased Risk of Infection Alterations in Cardiovascular/Renal Function Gastrointestinal Perforation Behavioral and Mood Disturbances Effects on Bones Ophthalmic Effects Immunizations Serious Skin Rashes Effects on Growth and Development Myopathy Kaposi’s Sarcoma Thromboembolic…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
